![]() |
Accenture and ICRI have partnered to jointly develop a pharmacovigilance and clinical research programme for the Indian market. Related news |
Quintiles will help Australian drugmaker Pharmaxis launch its cystic fibrosis treatment Bronchitol in Europe under a contract announced yesterday.
Asuragen is introducing KRAS and BRAF mutational testing services to support development of personalised colorectal cancer treatments.
Boehringer Ingelheim has opened its ‘Centre of Competence’ (CoC) in Shanghai to optimise API and chemical intermediates sourcing in China.
Retention strategies, trial site evaluations and dedicated budgets should be used to recruit patients to, and keep them in, clinical trials, according to research.
NanGenex is introducing GMP bench-top and pilot plant reactors to scale-up its process for the continuous production of nanostructured active ingredients.
Ranbaxy is latest firm targeting South African growth with a new £30m (€24m) Johannesburg tablet and capsule manufacturing plant.
US formulation services provider Bend Research has received a new patent for the process of producing spray-dried solid amorphous dispersions of drugs using single-fluid pressure nozzles.
iBio, CMB and GE Healthcare are collaborating on developing and marketing biopharm production systems, including plant-based expression technology.
|
|
Patient safety
More news |
|
|
Consolidation
More news |
Forming a strategic partnership with a CRO is one of the key steps to boosting patient recruitment, according to a report...